These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29382825)

  • 1. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.
    Scuderi C; Bronzuoli MR; Facchinetti R; Pace L; Ferraro L; Broad KD; Serviddio G; Bellanti F; Palombelli G; Carpinelli G; Canese R; Gaetani S; Steardo L; Steardo L; Cassano T
    Transl Psychiatry; 2018 Jan; 8(1):32. PubMed ID: 29382825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
    J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
    Bronzuoli MR; Facchinetti R; Steardo L; Romano A; Stecca C; Passarella S; Steardo L; Cassano T; Scuderi C
    Oxid Med Cell Longev; 2018; 2018():4720532. PubMed ID: 29576849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
    Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN
    J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease.
    Magistri M; Velmeshev D; Makhmutova M; Patel P; Sartor GC; Volmar CH; Wahlestedt C; Faghihi MA
    Curr Alzheimer Res; 2016; 13(9):985-95. PubMed ID: 27117003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    Bellanti F; Bukke VN; Moola A; Villani R; Scuderi C; Steardo L; Palombelli G; Canese R; Beggiato S; Altamura M; Vendemiale G; Serviddio G; Cassano T
    Front Aging Neurosci; 2022; 14():890855. PubMed ID: 35686025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
    Scuderi C; Stecca C; Valenza M; Ratano P; Bronzuoli MR; Bartoli S; Steardo L; Pompili E; Fumagalli L; Campolongo P; Steardo L
    Cell Death Dis; 2014 Sep; 5(9):e1419. PubMed ID: 25210802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
    D'Agostino G; Russo R; Avagliano C; Cristiano C; Meli R; Calignano A
    Neuropsychopharmacology; 2012 Jun; 37(7):1784-92. PubMed ID: 22414817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
    Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
    Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer's Disease.
    Sundaram JR; Poore CP; Sulaimee NHB; Pareek T; Cheong WF; Wenk MR; Pant HC; Frautschy SA; Low CM; Kesavapany S
    J Alzheimers Dis; 2017; 60(4):1429-1442. PubMed ID: 29036814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer's Disease.
    Beggiato S; Tomasini MC; Cassano T; Ferraro L
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
    Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
    BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
    Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
    CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.